US 11,732,305 B2
Method and kit for diagnosing early stage pancreatic cancer
Ajay Maker, Evanston, IL (US)
Assigned to The Board of Trustees of the University of Illinois, Urbana, IL (US)
Appl. No. 16/499,389
Filed by THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS, Urbana, IL (US)
PCT Filed Mar. 29, 2018, PCT No. PCT/US2018/025027
§ 371(c)(1), (2) Date Sep. 30, 2019,
PCT Pub. No. WO2018/183603, PCT Pub. Date Oct. 4, 2018.
Claims priority of provisional application 62/478,860, filed on Mar. 30, 2017.
Prior Publication US 2021/0102255 A1, Apr. 8, 2021
Int. Cl. C12Q 1/6886 (2018.01)
CPC C12Q 1/6886 (2013.01) [C12Q 2600/112 (2013.01); C12Q 2600/158 (2013.01)] 12 Claims
 
1. A kit for differentiating between high-risk and low-risk intraductal papillary mucinous neoplasms and the level of cyst dysplasia, comprising primer sets for amplifying biomarker RNAs,
wherein the primer sets are barcoded.